By IDSE News Staff
Although children who develop Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) may experience high rates of complications, death and recurrence are rare. But treatment strategies vary widely among health care providers (J Allergy Clin Immunol Pract 2018 May 30. [Epub ahead of print]).
Researchers from the University of Illinois at Chicago (UIC) conducted a large-scale analysis of treatments and outcomes for children with the rare skin conditions SJS and its